A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
Member of the 2019 Expert Review Committee for the Access to Medicine Index

Kawaldip Sehmi

Kawaldip Sehmi is a member of the 2019 Expert Review Committee for the Access to Medicine Index. 

Kawaldip is CEO of the International Alliance of Patients’ Organizations. He has an academic background in Public Health and Law. His previous positions include Managing Director of an international children’s legal centre, where he led a team of international lawyers working on the rights of the child, including the right to health. He has also served as CEO of an international mental health charity specialising in niche mental health services supporting young people and adults with complex mental health, personality disorder and substance misuse problems.

Kawaldip is a passionate advocate of personalised health care and the WHO’s human rights-based approaches to health, and the strengthening of the standards framework needed to support the achievement of health in all of the Sustainable Developmental Goals, including universal health coverage (SDG 3.8).

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |